Lpl Financial LLC Neurocrine Biosciences Inc Transaction History

Lpl Financial LLC

  • $320 Billion
  • Q3 2025

A detailed history of Lpl Financial LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Lpl Financial LLC holds 34,190 shares of NBIX stock, worth $4.95 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
34,190
Previous 29,670 15.23%
Holding current value
$4.95 Million
Previous $3.73 Million 28.69%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025
BUY
$123.98 - $146.67 $560,389 - $662,948
4,520 Added 15.23%
34,190 $4.8 Million
Q2 2025

Aug 12, 2025
BUY
$87.54 - $128.18 $1.17 Million - $1.71 Million
13,355 Added 81.86%
29,670 $3.73 Million
Q1 2025

May 07, 2025
SELL
$107.22 - $153.29 $47,069 - $67,294
-439 Reduced 2.62%
16,315 $1.8 Million
Q4 2024

Feb 11, 2025
BUY
$111.62 - $139.44 $406,631 - $507,979
3,643 Added 27.79%
16,754 $2.29 Million
Q3 2024

Nov 08, 2024
BUY
$114.58 - $153.15 $89,716 - $119,916
783 Added 6.35%
13,111 $1.51 Million
Q2 2024

Aug 07, 2024
SELL
$130.86 - $143.19 $30,359 - $33,220
-232 Reduced 1.85%
12,328 $1.7 Million
Q1 2024

May 10, 2024
BUY
$130.4 - $143.74 $356,383 - $392,841
2,733 Added 27.81%
12,560 $1.73 Million
Q4 2023

Feb 14, 2024
BUY
$106.07 - $132.76 $1,378 - $1,725
13 Added 0.13%
9,827 $1.29 Million
Q3 2023

Nov 13, 2023
BUY
$94.02 - $117.1 $150,432 - $187,360
1,600 Added 19.48%
9,814 $1.1 Million
Q2 2023

Jul 31, 2023
BUY
$89.53 - $104.87 $1,880 - $2,202
21 Added 0.26%
8,214 $774,000
Q1 2023

May 10, 2023
SELL
$94.11 - $123.02 $283,835 - $371,028
-3,016 Reduced 26.91%
8,193 $829,000
Q4 2022

Feb 07, 2023
SELL
$106.72 - $127.06 $456,548 - $543,562
-4,278 Reduced 27.62%
11,209 $1.34 Million
Q3 2022

Nov 14, 2022
SELL
$92.03 - $107.81 $136,296 - $159,666
-1,481 Reduced 8.73%
15,487 $1.65 Million
Q2 2022

Aug 12, 2022
SELL
$75.79 - $100.07 $87,689 - $115,780
-1,157 Reduced 6.38%
16,968 $1.65 Million
Q1 2022

May 16, 2022
SELL
$72.45 - $94.81 $94,040 - $123,063
-1,298 Reduced 6.68%
18,125 $1.7 Million
Q4 2021

Feb 14, 2022
SELL
$79.65 - $106.22 $110,235 - $147,008
-1,384 Reduced 6.65%
19,423 $1.65 Million
Q3 2021

Nov 15, 2021
BUY
$86.18 - $99.03 $572,579 - $657,955
6,644 Added 46.91%
20,807 $2 Million
Q2 2021

Aug 13, 2021
BUY
$89.43 - $102.27 $684,497 - $782,774
7,654 Added 117.59%
14,163 $1.38 Million
Q1 2021

May 14, 2021
SELL
$87.57 - $119.4 $178,204 - $242,979
-2,035 Reduced 23.82%
6,509 $633,000
Q4 2020

Feb 12, 2021
BUY
$86.91 - $108.33 $59,967 - $74,747
690 Added 8.79%
8,544 $819,000
Q3 2020

Nov 09, 2020
BUY
$96.16 - $135.15 $160,587 - $225,700
1,670 Added 27.01%
7,854 $755,000
Q2 2020

Aug 13, 2020
BUY
$85.09 - $130.36 $32,844 - $50,318
386 Added 6.66%
6,184 $754,000
Q1 2020

May 14, 2020
SELL
$75.11 - $113.76 $15,097 - $22,865
-201 Reduced 3.35%
5,798 $502,000
Q4 2019

Feb 14, 2020
BUY
$86.8 - $118.57 $226,895 - $309,941
2,614 Added 77.22%
5,999 $645,000
Q3 2019

Nov 13, 2019
SELL
$83.82 - $101.5 $18,188 - $22,025
-217 Reduced 6.02%
3,385 $305,000
Q2 2019

Aug 09, 2019
SELL
$72.24 - $91.27 $68,555 - $86,615
-949 Reduced 20.85%
3,602 $304,000
Q1 2019

May 08, 2019
BUY
$69.31 - $91.53 $45,536 - $60,135
657 Added 16.87%
4,551 $401,000
Q4 2018

Feb 07, 2019
BUY
$68.32 - $124.36 $266,038 - $484,257
3,894 New
3,894 $278,000

Others Institutions Holding NBIX

# of Institutions
731
Shares Held
102M
Call Options Held
230K
Put Options Held
477K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $13.9B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email